Bedside To Bench: New Pathways For Understanding IBD
Dr. Aida Habtezion and Stanford University make promising advances through technology and collaboration.
Researchers
Below are researchers funded by the Kenneth Rainin Foundation who are working in immunity and inflammation.
Gloria Choi, PhD
Associate Professor, Massachusetts Institute of Technology, Current Grantee
The Choi lab studies the immune system and brain interaction, and its effects on neurodevelopment, behavior and mood. They seek to learn how cytokines may act as neuromodulators influencing the development and activity of neurons in…
Jean-Frederic Colombel, MD
Professor, Icahn School of Medicine at Mount Sinai; Director, Helmsley IBD Center; Former Grantee
By coordinating collaborative multi-disciplinary research efforts and public-private consortium, Dr. Colombel implements major clinical trials that have the potential to significantly improve treatments for patients across the spectrum of IBD.
Marco Colonna, MD
Professor, Washington University School of Medicine in St. Louis, Former Grantee
The Colonna lab is broadly interested in innate immunity, focused in two main areas related to IBD: 1) innate lymphoid cells in mucosal immunity and 2) plasmacytoid dendritic cells and IFNalpha/beta in host defense and autoimmunity.
Rafael Czepielewski, PhD
Assistant Professor, Augusta University Research Institute Inc, Current Grantee
The Czepielewski Lab investigates how chronic intestinal inflammation disrupts mucosal immune balance and tolerance by remodeling the lymphatic vasculature in Inflammatory Bowel Diseases, aiming to unravel new mechanisms to restore barrier health.
Michael Davis, PhD
Professor, University of Missouri, Former Grantee
Dr. Davis’s lab focuses on the mechanical and electrophysiological properties of lymphatic smooth muscle and endothelium and how dysfunction of those cell types contributes to lymphedema.
Lee Denson, MD
Professor, Cincinnati Children’s Hospital Medical Center, Current Grantee
Dr. Denson’s multi-center research program focuses on discovering underlying mechanisms and better therapeutic approaches in chronic inflammation, growth and mucosal healing related to adult and pediatric patients with IBD.
